» Articles » PMID: 31573857

Apparent Diffusion Coefficient Distinguishes Malignancy in T1-Hyperintense Small Renal Masses

Overview
Specialties Oncology
Radiology
Date 2019 Oct 2
PMID 31573857
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Small renal masses (< 4 cm) can be difficult to accurately classify as benign or malignant, particularly when they appear T1 hyperintense on MRI. This intrinsic signal, potentially related to intralesional hemorrhage, may limit evaluation of signal intensity on DWI. The purpose of this study was to test whether apparent diffusion coefficient (ADC) measurements may distinguish malignancy. This single-center retrospective study identified patients with a T1-hyperintense renal mass less than 4 cm on MRI. Malignant lesions were pathologically proven; a benign mass was established by a predefined hierarchy of pathologic proof, follow-up ultrasound, or follow-up imaging showing more than 5 years of stability. T1 hyperintensity, defined as a signal intensity equivalent to or greater than the adjacent renal cortex, was confirmed by a senior abdominal radiologist. Two additional abdominal radiologists independently measured ADC of the lesion, which was normalized to the ADC of the background ipsilateral kidney and represented as ADC. The final cohort included 58 benign and 37 malignant renal lesions in 95 patients. Interrater agreement for ADC measurements was almost perfect (κ = 0.836-0.934). ADC was significantly lower in malignant compared with benign lesions (0.65 ± 0.29 vs 1.03 ± 0.32; < 0.001). Malignant lesions were significantly larger than benign lesions (2.66 ± 0.86 cm vs 1.50 ± 0.65 cm; < 0.001); however, after controlling for lesion size, ADC remained a significant predictor of malignancy ( < 0.001). ADC was highly reproducible for T1-hyperintense small renal masses and was significantly lower in malignant compared with benign renal masses.

Citing Articles

MRI for the detection of small malignant renal masses: a systematic review and meta-analysis.

Shang W, Hong G, Li W Front Oncol. 2023; 13:1194128.

PMID: 37876965 PMC: 10591109. DOI: 10.3389/fonc.2023.1194128.


Multiparametric magnetic resonance imaging for characterizing renal tumors: A validation study of the algorithm presented by Cornelis .

Pietersen P, Lynggard Bo Madsen J, Asmussen J, Lund L, Nielsen T, Pedersen M J Clin Imaging Sci. 2023; 13:7.

PMID: 36908585 PMC: 9992978. DOI: 10.25259/JCIS_124_2022.

References
1.
Egbert N, Caoili E, Cohan R, Davenport M, Francis I, Kunju L . Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol. 2013; 201(2):347-55. DOI: 10.2214/AJR.12.9451. View

2.
Hecht E, Israel G, Krinsky G, Hahn W, Kim D, Belitskaya-Levy I . Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology. 2004; 232(2):373-8. DOI: 10.1148/radiol.2322031209. View

3.
Leroy X, Zini L, Leteurtre E, Zerimech F, Porchet N, Aubert J . Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol. 2002; 15(11):1126-30. DOI: 10.1097/01.MP.0000036346.88874.25. View

4.
Kang S, Zhang A, Pandharipande P, Chandarana H, Braithwaite R, Littenberg B . DWI for Renal Mass Characterization: Systematic Review and Meta-Analysis of Diagnostic Test Performance. AJR Am J Roentgenol. 2015; 205(2):317-24. DOI: 10.2214/AJR.14.13930. View

5.
Paschall A, Mirmomen S, Symons R, Pourmorteza A, Gautam R, Sahai A . Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement. Abdom Radiol (NY). 2018; 43(9):2424-2430. PMC: 8058623. DOI: 10.1007/s00261-017-1453-4. View